Current Environment: Production

Warning

An important message to our patients and their caregivers.

We are here for you. Read more

What is ornithine transcarbamylase (OTC) deficiency?

OTC deficiency is caused by mutations in the gene encoding the ornithine transcarbamylase (OTC) enzyme. This enzyme is responsible for detoxification of the ammonia that forms when proteins are broken down in the body. When there is not enough OT, ammonia builds up in the bloodstream. This can become toxic at high levels, potentially causing neurological impairments and eventual liver damage.

The most common form of OTC deficiency, occurring in both males and females, is a late-onset form. Although late-onset OTC deficiency is considered milder than neonatal-onset OTC deficiency, which affects newborns, it is still considered a serious condition. Currently, the only curative treatment is liver transplantation.

Ornithine Transcarbamylase Deficiency | Diagnosis & Treatments

Ornithine Transcarbamylase Deficiency | Programs & Services

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000 or click here to log into your MyChildrens portal.

For questions regarding an upcoming appointment, doctor notes, or specific questions related to symptoms or a diagnosis, please call the department of clinic directly.

Quick links:

- Global Services
- Find a Doctor
- Find a Location
- Programs and Services
- Conditions and Treatments
- Request an Appointment